Is 500 mg of Metformin a Low Dose? A Complete Dosage Guide

If you’ve been prescribed metformin 500 mg, you may be wondering whether that counts as a low dose. For many people, 500 mg is the starting point—but that doesn’t necessarily mean it is ineffective or that the dose will need to increase.

Metformin dosing depends on why it is being used, which formulation you take, how well you tolerate it, your blood sugar response, and factors such as kidney function. A dose that is appropriate for one person may be different for another.

In this guide, we’ll explain where 500 mg fits into typical metformin dosing, why clinicians often start there, how dose increases are commonly approached, and when a lower dose may remain appropriate over the long term.

Important: This article is for educational purposes and is not a substitute for medical advice. Do not increase, decrease, or stop metformin without discussing it with your healthcare professional.

Is 500 mg of Metformin Considered a Low Dose?

Yes. For most adults taking metformin for type 2 diabetes, 500 mg per day is generally considered a low starting dose.

The purpose of beginning with a smaller amount is usually tolerability rather than maximum glucose-lowering effect. Metformin commonly causes gastrointestinal symptoms when treatment begins, particularly nausea, diarrhea, abdominal discomfort, and cramping.

Starting at 500 mg gives the body an opportunity to adjust before a clinician considers increasing the dose.

However, calling 500 mg "low" does not mean it is automatically inadequate. Some people may remain on a lower dose because of tolerability, their treatment goals, the condition being treated, or other health considerations.

The key question isn't simply "Is 500 mg low?" It's "Is 500 mg appropriate for the reason I'm taking metformin?"

The Full Metformin Dose Chart

The following table summarizes commonly referenced dosing ranges. Actual prescribing decisions should be individualized by a healthcare professional.

Immediate-Release Metformin

Use case

Starting dose

Common maintenance

Maximum

Type 2 diabetes in adults

500 mg once or twice daily

1,000 mg twice daily

2,550 mg/day

Prediabetes*

500 mg once daily

850–1,700 mg/day

2,000 mg/day

PCOS*

500 mg once daily

Up to 1,500 mg/day

2,000 mg/day

Adjunct to GLP-1 therapy*

500 mg once daily

Around 1,000 mg/day

2,000 mg/day

Children ages 10–16 with type 2 diabetes

500 mg twice daily

1,000 mg twice daily

2,000 mg/day

*Use for these indications may be off-label depending on the condition and jurisdiction.

Extended-Release Metformin

Use case

Starting dose

Common maintenance

Maximum

Type 2 diabetes in adults

500 mg once daily with the evening meal

1,500–2,000 mg once daily

2,000 mg/day

These figures illustrate why 500 mg is generally viewed as the lower end of metformin therapy. For many adults with type 2 diabetes, treatment may eventually move toward a higher maintenance dose. But the appropriate amount depends on the individual's response and tolerance.

Why Do Doctors Start Metformin at 500 mg?

There is a practical reason clinicians often start low: the digestive system may need time to adjust.

Metformin can cause gastrointestinal symptoms, especially during the first few weeks. Taking a large dose immediately can make these effects more noticeable and may cause some people to stop treatment altogether.

A gradual approach allows clinicians to balance glucose control with tolerability.

Common Early Side Effects

People starting metformin may experience:

• Nausea

• Loose stools or diarrhea

• Abdominal discomfort

• Cramping

• Bloating

• Changes in taste

These symptoms often improve as the body becomes accustomed to the medication.

Taking metformin with food can also help reduce gastrointestinal discomfort, although patients should follow the instructions supplied with their specific prescription.

Why Slow Titration Can Help

Rather than immediately moving to a full maintenance dose, clinicians may increase metformin gradually.

If gastrointestinal symptoms become troublesome after an increase, a clinician may recommend remaining at the current dose longer or adjusting the treatment approach.

The goal isn't to reach a particular number as quickly as possible. The goal is to find a dose that provides appropriate benefit without causing unacceptable problems.

How Is Metformin Usually Titrated?

There isn't one universal titration schedule. The timing depends on the formulation, treatment goal, blood glucose response, and individual tolerance.

A commonly used example for immediate-release metformin is:

Treatment period

Example dose

Purpose

Weeks 1–2

500 mg once daily

Initial adjustment

Weeks 3–4

500 mg twice daily

Gradual increase

Weeks 5–6

1,000 mg twice daily

Possible maintenance range

Week 7 onward

Individualized

Adjust according to response and tolerance

This is an illustrative schedule, not a personal dosing recommendation.

Some people need longer at each stage. Others may not need to reach the higher doses shown above.

If gastrointestinal symptoms appear after an increase, a healthcare professional may slow the titration rather than continuing to increase the dose.

Extended-Release Metformin May Be Easier to Tolerate

Metformin comes in both immediate-release and extended-release formulations.

Immediate-release metformin is commonly taken more than once a day. Extended-release versions are generally designed to release the medication more gradually and are often taken once daily.

A typical XR progression may look like this:

Treatment period

Example dose

Purpose

Weeks 1–2

500 mg once daily

Initial dose

Weeks 3–4

1,000 mg once daily

Possible increase

Weeks 5–6

1,500 mg once daily

Possible maintenance

Week 7 onward

Up to 2,000 mg once daily

Individualized adjustment

Again, the actual schedule should come from the prescribing clinician.

For people who struggle with gastrointestinal symptoms on immediate-release metformin, an extended-release formulation may sometimes be considered.

Immediate-Release vs. Extended-Release Metformin

The two formulations contain the same active medication, but they deliver it differently.

Immediate-Release Metformin

Immediate-release formulations are absorbed relatively quickly and are commonly divided into multiple daily doses.

They can be effective and are often inexpensive, but some people experience more gastrointestinal discomfort.

Extended-Release Metformin

Extended-release formulations release metformin more gradually.

They are generally taken once daily, often with the evening meal, depending on the specific product.

Some patients find XR easier to tolerate, particularly when immediate-release metformin causes persistent digestive symptoms.

Comparing Daily Amounts

The total daily amount may be distributed differently between formulations.

Immediate-release total daily amount

Extended-release equivalent

500 mg twice daily

1,000 mg once daily

850 mg twice daily

1,700 mg once daily

1,000 mg twice daily

2,000 mg once daily

These are general comparisons rather than instructions for switching formulations. Different products have their own prescribing information, so a clinician or pharmacist should guide any change.

Does Metformin Dose Depend on the Condition?

Absolutely.

One of the biggest misconceptions about metformin is that everyone should eventually take the same amount.

Metformin is used for different purposes, and some uses are outside its FDA-approved indications. Consequently, dosing can vary considerably.

Type 2 Diabetes

For adults with type 2 diabetes, metformin is commonly started at a relatively low dose and gradually increased when appropriate.

A daily amount around 1,500–2,000 mg is commonly used as a maintenance range, although some people require less and others may be prescribed different amounts.

The objective is to improve blood glucose control while keeping side effects manageable.

Prediabetes

Metformin is sometimes prescribed for people with prediabetes, although lifestyle interventions remain central to diabetes prevention.

The Diabetes Prevention Program found that metformin reduced progression to type 2 diabetes compared with placebo, with the benefit varying according to the characteristics of the participants.

Doses used in research have included 850 mg twice daily, but clinical prescribing may involve lower amounts depending on the individual.

Polycystic Ovary Syndrome

Metformin is also used off-label in some people with polycystic ovary syndrome.

It may be considered when insulin resistance or metabolic concerns are part of the clinical picture.

Some treatment approaches begin at 500 mg daily and increase gradually if appropriate. A higher dose is not automatically better, particularly when gastrointestinal tolerance becomes an issue.

Metformin Alongside GLP-1 Therapy

Some patients use metformin alongside a GLP-1 receptor agonist when their healthcare professional believes combination treatment is appropriate.

Lower metformin amounts may be sufficient in some situations, particularly when the goal is to complement another glucose-lowering medication.

Because both treatments can affect the gastrointestinal system, careful clinical management is important.

Gestational Diabetes

Metformin is used in pregnancy in some healthcare systems, but its role varies by country and clinical circumstances.

In the United States, insulin has traditionally been preferred when medication is required for gestational diabetes.

Anyone who is pregnant or planning pregnancy should discuss diabetes treatment directly with their obstetric and diabetes-care team.

Metformin and Longevity Research

Metformin has also attracted interest in aging and longevity research.

Researchers have investigated whether its metabolic effects could have implications beyond diabetes treatment. However, longevity or anti-aging use remains investigational.

Metformin is not currently approved specifically as a longevity medication, and research findings should not be interpreted as a recommendation to take it for this purpose.

When Can 500 mg Be an Appropriate Long-Term Dose?

Although 500 mg is often a starting dose, it doesn't necessarily have to be temporary.

There are situations in which a clinician may decide that staying at a lower dose makes sense.

When Higher Doses Aren't Well Tolerated

Some people simply cannot tolerate higher amounts of metformin.

If increasing the dose repeatedly causes significant gastrointestinal symptoms, remaining at a lower dose may provide a better balance between benefit and tolerability.

When Metformin Is Being Used for an Off-Label Purpose

The amount used for conditions such as PCOS or prediabetes may differ from typical type 2 diabetes treatment.

The appropriate dose depends on the individual's circumstances and treatment objectives.

When Other Medications Are Also Being Used

Someone taking another glucose-lowering medication may not need the same metformin dose as someone relying primarily on metformin.

Treatment should therefore be evaluated as a complete medication plan rather than looking at metformin in isolation.

When Kidney Function Affects Treatment

Kidney function is particularly important when evaluating metformin therapy.

Metformin is eliminated primarily through the kidneys, and reduced kidney function can affect whether it is appropriate and how it should be used.

Patients with an estimated glomerular filtration rate (eGFR) between 30 and 45 mL/min/1.73 m² require particular caution, and metformin use may be limited depending on the clinical situation.

This is one reason kidney function should be assessed periodically during treatment.

Does a Higher Metformin Dose Work Better?

Not necessarily.

There is generally a relationship between metformin dose and glucose-lowering effect, particularly as treatment moves from very low doses toward commonly used therapeutic ranges.

But increasing the amount indefinitely does not produce proportionally greater benefits.

At higher doses, gastrointestinal side effects can become more problematic, while additional glucose-lowering benefit may become smaller.

That's why clinicians consider both effectiveness and tolerability when determining an appropriate maintenance dose.

A dose that looks "low" on paper can still be reasonable if it is producing the desired clinical response.

Metformin Side Effects and Dose

Gastrointestinal symptoms are among the most common problems associated with metformin.

They can include:

• Nausea

• Diarrhea

• Abdominal discomfort

• Gas

• Bloating

• Reduced appetite

• Metallic or altered taste

Higher doses can be more difficult for some people to tolerate, although individual responses vary considerably.

Rather than assuming that every side effect means metformin must be discontinued, patients should discuss persistent or severe symptoms with their healthcare professional.

Metformin and Vitamin B12

One long-term consideration that deserves attention is vitamin B12.

Long-term metformin use has been associated with reduced vitamin B12 levels in some patients. The risk can increase with longer treatment duration and may be influenced by the dose and other factors.

Potential signs of B12 deficiency can include:

• Fatigue

• Weakness

• Tingling or numbness

• Changes in balance

• Anemia

People taking metformin for an extended period may benefit from having their B12 status assessed when clinically appropriate.

Don't start supplementation solely because you're taking metformin. Discuss testing and supplementation with your healthcare professional.

What About Lactic Acidosis?

Lactic acidosis is a serious but rare complication associated with metformin.

The risk is particularly relevant when certain underlying conditions or circumstances are present, including significant kidney impairment and situations associated with tissue hypoxia or impaired lactate metabolism.

Because the complication is rare, the focus should not be on fear. Instead, appropriate patient selection, kidney-function assessment, medication review, and attention to acute illness help reduce risk.

If you're taking metformin and become seriously ill, particularly with dehydration or another significant medical problem, contact a healthcare professional for guidance about your medication.

How to Make Metformin Easier to Tolerate

If you've just started metformin, a few practical habits may make the adjustment period easier.

Take It With Food When Directed

Taking metformin with a meal can help reduce gastrointestinal discomfort. Follow the instructions specific to your prescription.

Don't Increase the Dose on Your Own

If 500 mg is your current dose, don't increase it simply because you think a higher amount will work faster.

Dose changes should be based on your glucose response, treatment goal, kidney function, other medications, and tolerance.

Give Your Body Time to Adjust

Digestive symptoms are often most noticeable early in treatment.

If symptoms are persistent or severe, speak with your clinician rather than simply stopping the medication.

Ask About Extended-Release Formulations

If immediate-release metformin continues to cause gastrointestinal problems, ask your healthcare professional whether an extended-release formulation could be appropriate.

Keep Follow-Up Appointments

Metformin treatment isn't just about choosing a number of milligrams.

Blood glucose, HbA1c, kidney function, other medications, and treatment goals may all influence whether your regimen needs adjustment.

What Should You Know About Metformin and Kidney Function?

Kidney health is one of the most important considerations when using metformin.

Because the medication is cleared through the kidneys, clinicians generally evaluate renal function before starting treatment and periodically afterward.

The FDA prescribing information includes important restrictions based on eGFR.

In particular, metformin should not be initiated in patients with an eGFR below 45 mL/min/1.73 m², and use is contraindicated when eGFR falls below 30 mL/min/1.73 m².

These thresholds can vary in how clinicians manage existing therapy, so anyone with reduced kidney function should discuss metformin with their healthcare team.

500 mg vs. 1,000 mg vs. 2,000 mg: What's the Difference?

It can be useful to think about the doses in broad terms.

500 mg

Usually considered a low starting amount. It may provide some metabolic benefit while allowing the digestive system to adjust.

1,000 mg

A commonly used total daily amount, depending on whether the medication is taken once or twice daily and which formulation is prescribed.

2,000 mg

A frequently used upper maintenance range for many extended-release regimens and a common total daily amount for immediate-release therapy.

However, these numbers shouldn't be interpreted as a progression that every patient must follow.

Some people remain at 500 mg. Others need a higher amount. Some cannot tolerate metformin at all.

The appropriate dose is the one that fits the person's clinical situation.

Does 500 mg of Metformin Help With Weight Loss?

Metformin isn't primarily a weight-loss medication.

Some people experience modest changes in weight while taking it, particularly when insulin resistance or metabolic disease is involved, but the results vary.

It should not be viewed as equivalent to medications specifically approved for chronic weight management.

If weight management is one of your goals, discuss evidence-based options with a qualified healthcare professional rather than increasing metformin in an attempt to produce greater weight loss.

Frequently Asked Questions

Is 500 mg of metformin a low dose?

Yes. For many adults with type 2 diabetes, 500 mg is considered a low starting dose. Whether it remains appropriate long term depends on the treatment goal, blood glucose response, tolerance, kidney function, and other factors.

Is 500 mg enough to control blood sugar?

It can provide glucose-lowering effects, but many adults with type 2 diabetes require a higher maintenance dose. Your HbA1c and blood glucose results help determine whether the current regimen is adequate.

How long do people stay on 500 mg?

There is no universal timeframe. Some people remain at 500 mg because they respond well or cannot tolerate higher doses. Others may have their dose adjusted after several weeks.

Is 500 mg of metformin used for PCOS?

Yes. Metformin may be prescribed off-label for PCOS, and some treatment plans begin with 500 mg before gradually increasing the amount if appropriate.

Is extended-release metformin better?

Not necessarily. Extended-release metformin may be easier for some people to tolerate, especially when gastrointestinal symptoms occur with immediate-release formulations. Both formulations can be effective.

Can metformin dosage be increased if 500 mg isn't working?

A clinician may increase the dose when appropriate, but this should be based on the individual's treatment response and medical circumstances rather than a fixed schedule.

The Bottom Line

So, is 500 mg of metformin a low dose? In most situations, yes—it sits near the lower end of commonly used dosing ranges and is frequently used as a starting amount.

But "low" doesn't mean "wrong" or "useless."

For someone beginning treatment, 500 mg can provide a gentler introduction to metformin while reducing the likelihood that gastrointestinal side effects will interfere with treatment. For some people, it may remain an appropriate long-term amount. Others may need a higher dose to achieve their treatment goals.

The right approach is not to chase the highest number on the dose chart. It's to find the lowest effective and tolerable regimen for the individual's circumstances.

If you're currently taking 500 mg and wondering whether you should increase it, don't make the change based solely on an online chart. Review your HbA1c or glucose results, side effects, kidney function, other medications, and overall treatment goals with your healthcare professional.

That conversation will tell you far more about whether 500 mg is "enough" than the number on the prescription bottle alone.

Sources

1. American Diabetes Association. Standards of Care in Diabetes: Pharmacologic Approaches to Glycemic Treatment. Diabetes Care. 2026.

2. Bristol-Myers Squibb. Glucophage and Glucophage XR (metformin) Prescribing Information. 2024.

3. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care. 2015 (updated 2018).

4. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin (DPP). N Engl J Med. 2002;346:393-403.

5. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101:1754-1761.

6. Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60:1586-1593.

7. National Institute of Diabetes and Digestive and Kidney Diseases. Metformin: Mechanism, Use, and Dosing. NIDDK. 2025.

8. American College of Obstetricians and Gynecologists. Polycystic Ovary Syndrome Practice Bulletin. ACOG. 2023.

9. U.S. Food and Drug Administration. FDA Drug Safety Communication: Revising the Label for Metformin in Patients with Reduced Kidney Function. April 2016.

10. Endocrine Society. Diagnosis and Treatment of Polycystic Ovary Syndrome Clinical Practice Guideline. 2023 Update.